Canada Life
SLDB icon

Canada Life’s Solid Biosciences SLDB Stock Holding History

Canada Life’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-114
Closed -$4K – 2800
2020
Q1 		$4K Hold
114
– – ﹤0.01% 2597
2019
Q4 		$8K Buy
+114
New +$12.6K ﹤0.01% 2590
2019
Q3 		– Sell
-215
Closed -$18K – 2097
2019
Q2 		$18K Hold
215
– – ﹤0.01% 2593
2019
Q1 		$29K Hold
215
– – ﹤0.01% 2333
2018
Q4 		$83K Buy
+215
New +$101K ﹤0.01% 2210

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Canada Life's SLDB Position: Q2 2020 in Review

Canada Life sold out of Solid Biosciences (SLDB) in Q2 2020, closing a stake of 114 shares — an estimated $4K sold.

Canada Life first reported a position in SLDB in Q4 2018 and held it in 5 quarters. The position peaked at $83K in Q4 2018. 66 funds tracked by Wall St. Rank hold SLDB as of Q2 2020.

  • Canada Life reported no remaining Solid Biosciences position as of Q2 2020 after selling out during the quarter.
  • Canada Life sold 114 Solid Biosciences shares in Q2 2020, an estimated $4K.
  • Canada Life first reported a position in Solid Biosciences in Q4 2018 and held it in 5 quarters.
  • Canada Life's Solid Biosciences position peaked at $83K in Q4 2018.
  • 66 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2020.

Based on Canada Life's 13F filing for Q2 2020, filed 17 Aug 2020.